Literature DB >> 402446

Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension.

W E Morton.   

Abstract

The symptoms of acute aliphatic nitrate toxicity are the same whether the exposure was to excess clinical medication or to percutaneous absorption during manufacture or packaging. In industrial exposures there is good evidence of chronic toxicity, with hazards of (a) increased risk of coronary pain and sudden death after withdrawal, and (b) increased risk of sustained hypertension in predisposed persons. On this basis we must suspect that certain types of therapy with aliphatic nitrate drugs might aggravate the course of coronary heart disease or hypertension. Should not these drugs be removed from the market until their long-term safety has been proved? Industrial experience with these chemicals has been incompletely reported, and more data are needed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402446

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  5 in total

Review 1.  Avoiding nitrate tolerance.

Authors:  J C Cowan
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

Review 2.  The medical treatment of angina pectoris.

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1987-12

3.  Abrupt cessation of short-term continuous treatment with isosorbide dinitrate may cause a rebound increase in silent myocardial ischaemia in patients with stable angina pectoris.

Authors:  S Y Martsevich; N Koutishenko; V I Metelitsa
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 4.  Ointments and transdermal nitroglycerin patches for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

Review 5.  Work-related cerebro-cardiovascular diseases in Korea.

Authors:  Dae-Seong Kim; Seong-Kyu Kang
Journal:  J Korean Med Sci       Date:  2010-12-15       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.